Table 3 Changes in cardiovascular risk factors
Usual care | Motivational intervention | |||||
|---|---|---|---|---|---|---|
Baseline1 mean ± SD 1vs4 p-value= | 12 months2 mean ± SD 2vs5 p-value= | 24 months3 mean ± SD 3vs6 p-value= | Baseline4 mean ± SD | 12 months5 mean ± SD | 24 months6 mean ± SD | |
Cholesterol | 208.5 ± 39.8 0.17 | 206.4 ± 34.9 0.78 | 206.7 ± 33.6 0.41 | 211.5 ± 36.6 | 207.5 ± 36.4 | 203.8 ± 36 |
Triglycerides | 135.4 ± (81.6) 0.21 | 134.7 ± 66.7 0.08 | 135.4 ± 65.6 0.0001 | 133.9 ± 93.9 | 127.6 ± 61.1 | 125.9 ± 65.1 |
HDL Cholesterol | 54.6 ± 13.1 0.66 | 53.4 ± 13.5 0.68 | 54.2 ± 13.7 0.41 | 55.3 ± 13.4 | 53.8 ± 11.9 | 55.4 ± 14.3 |
LDL Cholesterol | 131.6 ± 31.3 0.06 | 128.4 ± 33.8 0.08 | 126.4 ± 32.5 0.06 | 127.6 ± 32.6 | 125.9 ± 32.5 | 124.5 ± 35.9 |
APO A1 | 1.6 ± 0.3 0.15 | 1.6 ± 0.4 0.0002 | 1.5 ± 0.3 0.04 | 1.6 ± 0.3 | 1.7 ± 0.3 | 1.8 ± 0.3 |
APO B-100 | 1 ± 0.2 0.10 | 1 ± 0.2 0.30 | 0.9 ± 0.2 0.05 | 1 ± 0.2 | 0.9 ± 0.2 | 0.8 ± 0.2 |
APOB-100/APO-A1 | 0.62 ± 0.2 0.07 | 0.62 ± 0.3 0.002 | 0.55 ± 0.3 0.0003 | 0.62 ± 0.3 | 0.52 ± 0.3 | 0.44 ± 0.3 |
SBP | 130.8 ± 14.8 0.24 | 129.7 ± 15 0.29 | 131.7 ± 15.4 0.57 | 132.6 ± 15.2 | 130.9 ± 14.1 | 132.1 ± 14 |
DBP | 78.7 ± 10.3 0.44 | 78.6 ± 9 0.12 | 77.0 ± 9.2 0.17 | 79.3 ± 9.7 | 78.2 ± 9.1 | 78.0 ± 8.8 |